Characterization of a rabies virus isolate from a ferret badger (Melogale moschata) with unique molecular differences in glycoprotein antigenic site III

Virus Research

Volumn 149, Issue 2, 2010, Pages 143-151

  Zhang, Shoufeng ^a   Zhao, Jinghui ^a   Liu, Ye ^a   Fooks, Anthony R ^b,c   Zhang, Fei ^a   Hu, Rongliang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Dog rabies; Ferret badger; Isolate; Phylogeny; Street rabies virus; Wildlife

Indexed keywords

SIGNAL PEPTIDE; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL MEMBRANE; CHINA; CYTOPLASM; FERRET; FERRET BADGER; GENE SEQUENCE; LD 50; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PHYLOGENY; PRIORITY JOURNAL; RABIES VIRUS; SUCKLING; UNINDEXED SEQUENCE; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS ISOLATION; VIRUS VIRULENCE;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, VIRAL; BRAIN; CHINA; CLUSTER ANALYSIS; DOGS; EPITOPES; GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUSTELIDAE; MUTATION, MISSENSE; PHYLOGENY; RABIES VIRUS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; VIRAL ENVELOPE PROTEINS; VIRAL STRUCTURAL PROTEINS;

CANIS FAMILIARIS; MAMMALIA; MELOGALE MOSCHATA; MUS; MUSTELA; RABIES VIRUS; TAXIDIINAE;

EID: 77950630233     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.01.010     Document Type: Article

References (29)

1. Abreo C.B. A rapid quantitative microtest for live, attenuated rabies vaccine. J. Biol. Stand. 1985, 13:255-260.
2. Benmansour A., Leblois H., Coulon P., Tuffereau C., Gaudin Y., Flamand A., Lafay F. Antigenicity of rabies virus glycoprotein. J. Virol. 1991, 65:4198-4203.
3. Bordignon J., Brasil-Dos-Anjos G., Bueno C.R., Salvatiera-Oporto J., Dávila A.M., Grisard E.C., Zanetti C.R. Detection and characterization of rabies virus in Southern Brazil by PCR amplification and sequencing of the nucleoprotein gene. Arch. Virol. 2005, 150:695-708.
4. Bourhy H., Kissi B., Tordo N. Molecular diversity of the Lyssavirus genus. Virology 1993, 194:70-81.
5. Brown W.F. Variance estimation in the Reed-Muench fifty per cent end-point determination. Am. J. Hyg. 1964, 79:37-46.
6. Desmézières E., Maillard A.P., Gaudin Y., Tordo N., Perrin P. Differential stability and fusion activity of Lyssavirus glycoprotein trimers. Virus Res. 2003, 91:181-187.
7. Dietzschold B., Cox J.H., Schneider G. Structure and function of rabies virus glycoprotein. Dev. Biol. Stand. 1978, 40:45-55.
8. Dietzschold B., Wunner W.H., Wiktor T.J., Lopes A.D., Lafon M., Smith C.L., Koprowski H. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc. Natl. Acad. Sci. U.S.A. 1983, 80:70-74.
9. Faber M., Faber M.L., Papaneri A., Bette M., Weihe E., Dietzschold B., Schnell M.J. A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J. Virol. 2005, 79:14141-14148.
10. Ito H., Minamoto N., Watanabe T., Goto H., Rong L.T., Sugiyama M., Kinjo T., Mannen K., Mifune K., Konobe T., Yoshida I., Takamizawa A. A unique mutation of glycoprotein gene of the attenuated RC-HL strain of rabies virus, a seed virus used for production of animal vaccine in Japan. Microbiol. Immunol. 1994, 38:479-482.
11. Lafon M. Rabies virus receptors. J. Neurovirol. 2005, 11:82-87.
12. Markotter W., Kuzmin I., Rupprecht C.E., Nel L.H. Phylogeny of Lagos bat virus: challenges for lyssavirus taxonomy. Virus Res. 2008, 135:10-21.
13. McGettigan J.P., Pomerantz R.J., Siler C., McKenna P.M., Foley H.D., Dietzschold B., Schnell M.J. Second generation rabies-based vaccine vectors expressing HIV-1 gag have greatly reduced pathogenicity but are highly immunogenic. J. Virol. 2003, 77:237-244.
14. Mebatsion T. Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein. J. Virol. 2001, 75:11496-11502.
15. Meslin F.X. Global aspects of emerging and potential zoonoses: a WHO perspective. Emerg. Infect. Dis. 1997, 3:223-228.
16. Meslin F.X., Kaplan M.M., Koprowski H. Laboratory Techniques in Rabies 1996, WHO, Geneva, pp. 88-139. 4th ed.
17. Morimoto K., McGettigan J.P., Foley H.D., Hooper D.C., Dietzschold B., Schnell M.J. Genetic engineering of live rabies vaccines. Vaccine 2000, 19:3543-3551.
18. Nadin-Davis S.A., Casey G.A., Wandeler A.I. A molecular epidemiological study of rabies virus in central Ontario and western Quebec. J. Gen. Virol. 1994, 75:2575-2583.
19. Sato G., Kobayashi Y., Motizuki N., Hirano S., Itou T., Cunha E.M.S., Ito F.H., Sakai T. A unique substitution at position 333 on the glycoprotein of rabies virus street strains isolated from non-hematophagous bats in Brazil. Virus Genes 2009, 38:74-79.
20. Seif I., Coulon P., Rollin P.E., Flamand A. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site II of the glycoprotein. J. Virol. 1985, 53:926-934.
21. Shimizu K., Ito N., Mita T., Yamada K., Hosokawa-Muto J., Sugiyama M., Minamoto N. Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice. Virus Res. 2007, 123:154-160.
22. Takayama-Ito M., Ito N., Yamada K., Minamoto N., Sugiyama M. Region at amino acids 164 to 303 of the rabies virus glycoprotein plays an important role in pathogenicity for adult mice. J. Neurovirol. 2004, 10:131-135.
23. Takayama-Ito M., Inoue K., Shoji Y., Inoue S., Iijima T., Sakai T., Kurane I., Morimoto K. A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein. Virus Res. 2006, 119:208-215.
24. Takayama-Ito M., Ito N., Yamada K., Sugiyama M., Minamoto N. Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice. Virus Res. 2006, 115:169-175.
25. Tuffereau C., Leblois H., Bénéjean J., Coulon P., Lafay F., Flamand A. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 1989, 172:206-212.
26. Wunner W.H., Larson J.K., Dietzschold B., Smith C.L. The molecular biology of rabies viruses. Rev. Infect. Dis. 1988, 10:771-784.
27. Yamada K., Ito N., Takayama-Ito M., Sugiyama M., Minamoto N. Multigenic relation to the attenuation of rabies virus. Microbiol. Immunol. 2006, 50:25-32.
28. Yang C., Jackson A.C. Basis of neurovirulence of avirulent rabies virus variant Av01 with stereotaxic brain inoculation in mice. J. Gen. Virol. 1992, 73:895-900.
29. Zhang S.F., Tang Q., Wu X., Liu Y., Zhang F., Rupprecht C.E., Hu R. Rabies in ferret badgers, southeastern China. Emerg. Infect. Dis. 2009, 15(6):946-949.